Carlsmed COO Bertolini holds 22,489 shares, options
Form 3 discloses CARLSMED’s COO direct holdings of common stock, RSUs, and multiple stock option grants with staggered vesting schedules.
Rhea-AI Filing Summary
CARLSMED, INC. (CARL) reported the initial equity holdings of Chief Operating Officer Jeffrey Bertolini. He directly holds 22,489 shares of Common Stock, which includes restricted stock units that vest in three equal annual installments beginning January 28, 2026, subject to his continued service. He also holds stock options to acquire 35,714, 22,402 and 6,068 shares of Common Stock at exercise prices of $15.00, $5.92 and $2.23 per share, expiring between November 12, 2034 and July 21, 2035, with portions already vested and the remainder vesting over time, contingent on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Footnotes (4)
- F1. Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date, January 28, 2026, subject to the Reporting Person's continued service through each such vesting date.
- F2. Includes 35,714 stock options exercisable into 35,714 shares of the Issuer's common stock, which began to vest on July 22, 2025 and shall vest in equal installments on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each such vesting date. 8,928 of these stock options are fully vested and exercisable stock options and 26,786 of these stock options are unvested stock options and will be fully vested on July 22, 2029.
- F3. Includes 22,402 unvested stock options exercisable into 22,402 shares of the Issuer's common stock. The stock options (which represent a portion of an original grant of 35,842 stock options exercisable into approximately 35,842 shares of the Issuer's common stock (the "Original Grant")) began to vest on March 3, 2025, subject to a one-year cliff, and shall vest in equal installments on each monthly anniversary thereafter, subject to the Reporting Person's continued service through each such vesting date. The Reporting Person previously exercised 13,440 of the stock options from the Original Grant.
- F4. Includes 6,068 unvested stock options exercisable into 6,068 shares of the Issuer's common stock. The stock options (which represent a portion of an original grant of 11,649 stock options exercisable into approximately 11,649 shares of the Issuer's common stock (the "Original Grant")) began to vest on September 30, 2024, subject to a one-year cliff, and shall vest in equal installments on each monthly anniversary thereafter, subject to the Reporting Person's continued service through each such vesting date. The Reporting Person previously exercised 5,581 of these stock options from the Original Grant.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
stock options financial
vest financial
exercise price financial
cliff financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does CARLSMED (CARL) disclose in this Form 3 for its COO?
What stock options in CARL does the COO hold and at what exercise prices?
When do Jeffrey Bertolini’s CARL stock options expire?
What are the vesting terms of the CARL RSUs reported for the COO?
How many of the COO’s CARL stock options are already vested?
What prior exercises of CARL stock options by the COO are noted?
AI-generated analysis. How Rhea-AI works. Not financial advice.